MM&M partners with Step Up on 2019 Hall of Femme
A portion of all proceeds from nominations will be donated to the nonprofit.
-
-
Five things for pharma marketers to know: Thursday, November 15, 2018
FDA imposes restrictions on e-cigarette sales; Pfizer launches biosimilar to treat anemia; J&J cleared of liability in one talc case. -
Bid-process meddling investigation closed for Omnicom, MDC, Publicis, IPG and WPP
The shops were being probed after independent production companies accused advertising agencies of improper practices. -
Digital growth is killing creative quality, say most marketers
A new study suggests creative departments are struggling to keep up data-driven advertising.
LATEST NEWS
Healthcare execs optimistic about AI, survey says
Healthcare leaders expect to spend an average of $32 million implementing artificial intelligence into their business.
Five things for pharma marketers to know: Wednesday, November 14, 2018
Juul suspends flavored vape sales in retail stores, quits social media; Google health unit to absorb DeepMind AI health division; Indegene launches digital agency.
The path to accountability in POC
There has been more intrigue and discussion about the point-of-care environment over the past 18 months than in the last decade combined — and the news keeps on coming.
Fear and hope help healthcare marketing trigger action
People are more inclined to change their lives for the better when content is motivational instead of based on shock-value, study finds.
Five things for pharma marketers to know: Tuesday, November 13, 2018
Amarin CEO defends Vascepa trial results; Tech companies meet to discuss opioid epidemic; GSK to launch clinical program for pancreatic cancer.
Survey: Millennials just don’t trust their doctors
Healthcare companies will have to rethink how they communicate online with millennials as the generation makes more healthcare decisions.
Gilead names Michael Boyd VP of government affairs, policy
Boyd has worked at AbbVie, Pfizer, and Schering-Plough.
Five things for pharma marketers to know: Monday, November 12, 2018
Athenahealth sold for $5.7b; Driver shuts down; Combined Takeda-Shire could debut in January.
American Lung Association turns cancer into a true crime killer
The organization’s latest awareness campaign is taking cues from true crime shows.
Read the November 2018 Digital Edition
The November Digital Edition includes features on the 2018 Health Influencer 50, the agency of the future, and the evolution of clinical trial recruitment.
